Kirong, Baby Boy .
HRN: 23-05-41 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/09/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/09/2023
06/15/2023
IVT
32mg
Q24
Psnb
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes